SG11201601714UA - Novel triazolo[4,5-d]pyrimidine derivatives - Google Patents
Novel triazolo[4,5-d]pyrimidine derivativesInfo
- Publication number
- SG11201601714UA SG11201601714UA SG11201601714UA SG11201601714UA SG11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrimidine derivatives
- novel triazolo
- triazolo
- novel
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13183385 | 2013-09-06 | ||
| PCT/EP2014/068640 WO2015032769A1 (en) | 2013-09-06 | 2014-09-03 | Novel triazolo[4,5-d]pyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601714UA true SG11201601714UA (en) | 2016-04-28 |
Family
ID=49111076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601714UA SG11201601714UA (en) | 2013-09-06 | 2014-09-03 | Novel triazolo[4,5-d]pyrimidine derivatives |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US9593123B2 (ru) |
| EP (3) | EP3943497A1 (ru) |
| JP (1) | JP6441356B2 (ru) |
| KR (3) | KR20220140651A (ru) |
| CN (1) | CN105555788B (ru) |
| AR (1) | AR097553A1 (ru) |
| AU (1) | AU2014317229B2 (ru) |
| CA (1) | CA2915766C (ru) |
| CL (1) | CL2016000495A1 (ru) |
| CR (1) | CR20160076A (ru) |
| DK (2) | DK3041843T3 (ru) |
| EA (1) | EA028335B1 (ru) |
| ES (2) | ES2883923T3 (ru) |
| HK (1) | HK1219277A1 (ru) |
| HR (2) | HRP20190361T1 (ru) |
| HU (2) | HUE055201T2 (ru) |
| IL (1) | IL243092B (ru) |
| LT (2) | LT3041843T (ru) |
| MA (1) | MA38826B1 (ru) |
| MX (2) | MX367084B (ru) |
| MY (1) | MY191628A (ru) |
| PE (2) | PE20160691A1 (ru) |
| PH (1) | PH12016500250A1 (ru) |
| PL (2) | PL3483163T3 (ru) |
| PT (2) | PT3041843T (ru) |
| RS (2) | RS62234B1 (ru) |
| SG (1) | SG11201601714UA (ru) |
| SI (2) | SI3483163T1 (ru) |
| TR (1) | TR201900662T4 (ru) |
| TW (1) | TWI705966B (ru) |
| UA (1) | UA116395C2 (ru) |
| WO (1) | WO2015032769A1 (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015162630A1 (en) * | 2014-04-25 | 2015-10-29 | Anlon Chemical Research Organization | Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis. |
| EP3215506B1 (en) | 2014-11-07 | 2019-01-02 | F.Hoffmann-La Roche Ag | Triazolo[4,5-d]pyrimidines as agonists of the cannabinoid receptor 2 |
| WO2017004133A1 (en) * | 2015-06-29 | 2017-01-05 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| WO2017076266A1 (zh) * | 2015-11-06 | 2017-05-11 | 江苏恒瑞医药股份有限公司 | 制备坎格雷洛中间体的方法 |
| CN115093418A (zh) * | 2016-06-23 | 2022-09-23 | 豪夫迈·罗氏有限公司 | 对2型大麻素受体具有亲和力的[1,2,3]三唑并[4,5-d]嘧啶衍生物 |
| WO2017220544A1 (en) | 2016-06-23 | 2017-12-28 | F. Hoffmann-La Roche Ag | Novel[1,2,3]triazolo[4,5-d]pyrimidine derivatives |
| WO2018015088A1 (en) | 2016-06-23 | 2018-01-25 | F. Hoffmann-La Roche Ag | Novel [1,2,31triazolo[4,5-d]pyrimidine derivatives |
| CN109415366B (zh) * | 2016-06-23 | 2022-02-22 | 豪夫迈·罗氏有限公司 | [1,2,3]三唑并[4,5-d]嘧啶衍生物 |
| CN106478639B (zh) * | 2016-09-05 | 2018-09-18 | 郑州大学 | 嘧啶并1,2,4–三氮唑类的lsd1抑制剂、其制备方法及应用 |
| CN106432248B (zh) * | 2016-09-27 | 2018-11-27 | 郑州大学 | 含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用 |
| CN106432247B (zh) * | 2016-09-27 | 2018-06-29 | 郑州大学 | 含有腙键的嘧啶并三氮唑类化合物、制备方法及其应用 |
| CN106928296A (zh) * | 2017-02-06 | 2017-07-07 | 上海华升生物科技有限公司 | 一种2‑(3,3,3‑三氟丙硫基)腺苷的合成方法 |
| CN106928235A (zh) * | 2017-05-03 | 2017-07-07 | 郑州大学 | 含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用 |
| CN107033148B (zh) * | 2017-05-03 | 2018-10-26 | 郑州大学 | 含嘧啶并三氮唑—巯基四氮唑类lsd1抑制剂、其制备方法及应用 |
| CN109516990B (zh) * | 2017-09-19 | 2021-06-01 | 天津药物研究院有限公司 | 嘧啶并三氮唑类化合物、其制备方法和用途 |
| CN113582935A (zh) * | 2021-08-27 | 2021-11-02 | 中国医学科学院放射医学研究所 | 一种炎症小体核苷酸结合寡聚化结构域样受体蛋白3抑制剂及其制备方法和应用 |
| CN115246832B (zh) * | 2022-06-15 | 2024-05-24 | 深圳湾实验室 | 一类去泛素化酶usp25和usp28靶向抑制剂及制备和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001514260A (ja) | 1997-09-02 | 2001-09-11 | デュポン ファーマシューティカルズ カンパニー | Ｃｎｓおよびストレス関連疾患の治療に有用な、副腎皮質刺激ホルモン放出ホルモン拮抗剤としての、複素環基が置換した環縮合ピリジン類およびピリミジン類 |
| JP2004502642A (ja) | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| US20060128708A1 (en) * | 2004-06-17 | 2006-06-15 | The Regents Of The University Of California | Antagonizing an adenosine A2A receptor to ameliorate one or more components of addictive behavior |
| AR051596A1 (es) | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
| EP2155747B1 (en) | 2007-05-10 | 2012-10-24 | GE Healthcare Limited | Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors |
| JP2011507910A (ja) * | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
| WO2009117444A1 (en) | 2008-03-17 | 2009-09-24 | Northeastern University | Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| WO2010120987A1 (en) | 2009-04-17 | 2010-10-21 | Wyeth Llc | Ring fused, ureidoaryl- and carbamoylaryl-bridged morpholino-pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| WO2013060837A1 (en) | 2011-10-27 | 2013-05-02 | Lek Pharmaceuticals D.D. | Synthesis of triazolopyrimidine compounds |
| UA111640C2 (uk) * | 2011-11-08 | 2016-05-25 | Ф. Хоффманн-Ля Рош Аг | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2 |
| US9067943B2 (en) * | 2011-11-25 | 2015-06-30 | Hoffmann-La Roche Inc. | [1,2,3]triazolo[4,5-D]pyrimidine derivatives |
| RU2015101818A (ru) | 2012-07-04 | 2016-08-27 | Ф.Хоффманн-Ля Рош Аг | Новые производные адамантила в качестве агонистов каннабиноидных рецепторов 2 |
| KR20150091080A (ko) | 2012-12-07 | 2015-08-07 | 에프. 호프만-라 로슈 아게 | Cb2 작용제로서 유용한 피리딘-2-아마이드 |
| KR20150092232A (ko) | 2012-12-07 | 2015-08-12 | 에프. 호프만-라 로슈 아게 | Cb2 작용제로 유용한 피리딘-2-아마이드 |
| PT2928881T (pt) | 2012-12-07 | 2018-05-07 | Hoffmann La Roche | Novos derivados de piridina |
| PT2928882T (pt) | 2012-12-07 | 2017-03-16 | Hoffmann La Roche | Derivados de pirazina como agonistas do recetor de cb2 |
| SI2964646T1 (sl) | 2013-03-07 | 2017-08-31 | F. Hoffmann-La Roche Ag | Novi derivati pirazola |
| SG11201509029PA (en) | 2013-05-02 | 2015-12-30 | Hoffmann La Roche | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists |
| WO2014177490A1 (en) | 2013-05-02 | 2014-11-06 | F. Hoffmann-La Roche Ag | Purine derivatives as cb2 receptor agonists |
| EP3008055B1 (en) | 2013-06-11 | 2017-07-19 | F. Hoffmann-La Roche AG | Tetrazolone derivatives |
-
2014
- 2014-09-03 HU HUE18206943A patent/HUE055201T2/hu unknown
- 2014-09-03 PT PT14761320T patent/PT3041843T/pt unknown
- 2014-09-03 PL PL18206943T patent/PL3483163T3/pl unknown
- 2014-09-03 ES ES18206943T patent/ES2883923T3/es active Active
- 2014-09-03 SI SI201431869T patent/SI3483163T1/sl unknown
- 2014-09-03 ES ES14761320T patent/ES2714094T3/es active Active
- 2014-09-03 WO PCT/EP2014/068640 patent/WO2015032769A1/en active Application Filing
- 2014-09-03 MX MX2016002117A patent/MX367084B/es active IP Right Grant
- 2014-09-03 EA EA201690478A patent/EA028335B1/ru not_active IP Right Cessation
- 2014-09-03 PT PT182069435T patent/PT3483163T/pt unknown
- 2014-09-03 MY MYPI2016700721A patent/MY191628A/en unknown
- 2014-09-03 EP EP21179163.7A patent/EP3943497A1/en active Pending
- 2014-09-03 PL PL14761320T patent/PL3041843T3/pl unknown
- 2014-09-03 LT LTEP14761320.2T patent/LT3041843T/lt unknown
- 2014-09-03 LT LTEP18206943.5T patent/LT3483163T/lt unknown
- 2014-09-03 KR KR1020227034655A patent/KR20220140651A/ko not_active Application Discontinuation
- 2014-09-03 HU HUE14761320A patent/HUE041760T2/hu unknown
- 2014-09-03 CN CN201480048593.7A patent/CN105555788B/zh active Active
- 2014-09-03 CA CA2915766A patent/CA2915766C/en active Active
- 2014-09-03 SG SG11201601714UA patent/SG11201601714UA/en unknown
- 2014-09-03 PE PE2015002700A patent/PE20160691A1/es unknown
- 2014-09-03 RS RS20211007A patent/RS62234B1/sr unknown
- 2014-09-03 DK DK14761320.2T patent/DK3041843T3/en active
- 2014-09-03 TR TR2019/00662T patent/TR201900662T4/tr unknown
- 2014-09-03 UA UAA201603048A patent/UA116395C2/uk unknown
- 2014-09-03 EP EP18206943.5A patent/EP3483163B1/en active Active
- 2014-09-03 KR KR1020217017887A patent/KR102454344B1/ko active Application Filing
- 2014-09-03 SI SI201431099T patent/SI3041843T1/sl unknown
- 2014-09-03 JP JP2016539509A patent/JP6441356B2/ja active Active
- 2014-09-03 KR KR1020167008516A patent/KR102349567B1/ko active IP Right Grant
- 2014-09-03 DK DK18206943.5T patent/DK3483163T3/da active
- 2014-09-03 RS RS20190264A patent/RS58390B1/sr unknown
- 2014-09-03 PE PE2019001869A patent/PE20191528A1/es unknown
- 2014-09-03 EP EP14761320.2A patent/EP3041843B1/en active Active
- 2014-09-03 AU AU2014317229A patent/AU2014317229B2/en active Active
- 2014-09-04 TW TW103130651A patent/TWI705966B/zh active
- 2014-09-04 AR ARP140103305A patent/AR097553A1/es active IP Right Grant
-
2015
- 2015-12-14 IL IL243092A patent/IL243092B/en active IP Right Grant
-
2016
- 2016-02-04 PH PH12016500250A patent/PH12016500250A1/en unknown
- 2016-02-04 MA MA38826A patent/MA38826B1/fr unknown
- 2016-02-16 CR CR20160076A patent/CR20160076A/es unknown
- 2016-02-17 MX MX2019009100A patent/MX2019009100A/es unknown
- 2016-02-23 US US15/050,753 patent/US9593123B2/en active Active
- 2016-03-04 CL CL2016000495A patent/CL2016000495A1/es unknown
- 2016-06-23 HK HK16107348.6A patent/HK1219277A1/zh unknown
-
2019
- 2019-02-25 HR HRP20190361TT patent/HRP20190361T1/hr unknown
-
2021
- 2021-08-16 HR HRP20211322TT patent/HRP20211322T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL243092B (en) | New triazolo[d–4,5]pyrimidine histories | |
| HRP20181349T1 (hr) | Derivat tetrahidroimidazo[1,5-d][1,4]oksazepina | |
| HK1245764A1 (zh) | 3-取代的5-氨基-6h-噻唑並[4，5-d]嘧啶-2，7-二酮化合物 | |
| ZA201506570B (en) | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents | |
| IL254224A0 (en) | 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors | |
| HK1206014A1 (en) | Pyrazolo triazine derivatives as selective cyclin dependent kinase inhinitors | |
| EP3067356A4 (en) | Pyrrolo pyrimidine derivative | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| PL2694513T3 (pl) | Pochodne pirazolopirymidynowe | |
| ZA201507151B (en) | Antiviral indolo[2,3-b]quinoxaline | |
| TH1601001194A (th) | อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่ | |
| GB201219129D0 (en) | Triazolo(4,5-d)pyrmindine compounds |